You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Claims for Patent: 11,197,830


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,197,830
Title:Pharmaceutical composition containing acetaminophen and ibuprofen
Abstract:Solid oral dosage forms containing 325 mg of acetaminophen and 97.5 mg of ibuprofen or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 1 and 9 μm, are described.
Inventor(s):Murphy Maura, Callahan Matt
Assignee:
Application Number:US16287836
Patent Claims: 2. The tablet of claim 1 , wherein the ibuprofen has a [D10] between 1 and 3 μm.3. The tablet of claim 1 , wherein the ibuprofen has a [D90] between 3 and 16 μm.4. The tablet of claim 1 , wherein the ibuprofen has a [D50] between 2 and 8 μm claim 1 , a [D10] between 1 and 3 μm and a [D90] between 4 and 16 μm.5. The tablet of wherein the dissolution rate of ibuprofen in the solid oral dosage form is such that claim 1 , when tested using USP Apparatus II (paddles) set to rotation speed of 50 rpm in 900 mL of 50 mM pH 5.8 phosphate buffer at 37° C. claim 1 , wherein 80% or more of the ibuprofen dissolves in 15 minutes or less.6. The tablet of claim 5 , wherein at least 85% to 95% of the ibuprofen dissolves in 15 minutes or less.7. The tablet of claim 5 , wherein at least 95% to 100% of the ibuprofen dissolves in 10 minutes or less.8. The tablet of claim 1 , wherein the tablet is coated.9. The tablet of claim 1 , wherein the [D90] to [D50] ratio is between 3:1 and 1.5:1.10. The tablet of claim 1 , wherein the [D50] to [D10] ratio is between 4:1 and 1.5:1.11. The tablet of claim 1 , wherein the [D50] to [D10] ratio is between 3:1 and 1.5:1.12. The tablet of claim 1 , wherein the tablet is a coated tablet.13. The tablet of claim 1 , prepared by a process comprising jet milling a composition comprising 21-23% wt/wt ibuprofen and 73-75% wt/wt acetaminophen.14. The tablet of claim 1 , wherein the surfactant is sodium lauryl sulfate.15. The tablet of claim 5 , wherein 85% to 95% of the ibuprofen dissolves in 15 minutes.16. The tablet of claim 5 , wherein 95% to 100% of the ibuprofen dissolves in 10 minutes.17. A method for treating pain comprising administering a dose of 1 claim 1 , 2 or 3 units of the tablet of comprising 325 mg of acetaminophen and 97.5 mg of ibuprofen.18. The method of claim 17 , wherein the administration is 1 claim 17 , 2 claim 17 , 3 or 4 times daily.19. A method for treating pain comprising administering a dose of 1 or 2 units of the solid oral dosage form of comprising 500 mg of acetaminophen and 150 mg of ibuprofen.20. The method of claim 19 , wherein the administration is 1 claim 19 , 2 claim 19 , 3 or 4 times daily.21. The method of claim 17 , wherein the pain is mild to moderate acute pain.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.